Home About Domain Investment Team Portfolio Companies News Contact Us
6/8/2009
CELATOR PRESENTS DATA ON THE ACTIVITY OF CPX-351 AGAINST LEUKEMIA AT THE EUROPEAN HEMATOLOGY ASSOCIATION CONGRESS
6/1/2009
RELAXIN FOR AHF IS THE STRONGEST PREDICTOR OF IMPROVED LONGER-TERM OUTCOMES FOLLOWING HOSPITAL DISCHARGE WHEN COMPARED TO OTHER VARIABLES
5/28/2009
RESULTS AND ADDITIONAL ANALYSES FROM EFFICACY AND SAFETY STUDY OF CORTHERA’S RELAXIN IN ACUTE HEART FAILURE TO BE PRESENTED AT HEART FAILURE CONGRESS
5/21/2009
CLOVIS ONCOLOGY RAISES $145 MILLION IN START-UP FINANCING
 
History  
  Founded in 1985 to invest exclusively in emerging life sciences companies
Portfolio  
  Involved in the formation of more than 210 companies over the last 24 years
Experience  
  Team of experienced life-science professionals
Assets  
  $2 billion in capital under management
Locations  
  Offices in Princeton, NJ and San Diego, CA
 
Domain Associates, L.L.C. is a member of the National Venture Capital Association.
Web Design by Computer Solutions